Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unified gene expression signature of novel NPM1 exon 5 mutations in acute myeloid leukemia.

Blood advances - 13 Sept 2022

Lisi Véronique, Blanchard Ève, Vladovsky Michael, Audemard Éric, Feghaly Albert, Lemieux Sébastien, Hébert Josée, Sauvageau Guy, Lavallée Vincent-Philippe

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Exons
Share to Leukemia, Myeloid, Acute
Share to Nuclear Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Transcriptome

Source

Open in PubMed Open full text

Identifiers

PMID: 35849707
DOI: 10.1182/bloodadvances.2022007300
PMCID: PMC9631620

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unified gene expression signature of novel NPM1 exon 5 mutations in acute myeloid leukemia.PMID 35849707Read ↗

Biological and clinical consequences of NPM1 mutations in AML.Semantic proximity Read ↗

Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group.Semantic proximity Read ↗

Novel NPM1 mutation in the 3'-untranslated region identified in two patients with acute myeloid leukemia.Semantic proximity Read ↗

FLT3-ITD-associated gene-expression signatures in NPM1-mutated cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemiaSemantic proximity Read ↗

PLA2G4A Is a Potential Biomarker Predicting Shorter Overall Survival in Patients with Non-M3/ NPM1 Wildtype Acute Myeloid LeukemiaSemantic proximity Read ↗

Overlapping features of therapy-related and de novo NPM1-mutated AML.Semantic proximity Read ↗

Targeted therapy in NPM1-mutated AML: Knowns and unknownsSemantic proximity Read ↗

Clonal evolution of NPM1 gene mutation in relapsed normal karyotype acute myeloid leukemia.Semantic proximity Read ↗

A novel 5-gene prognostic signature to improve risk stratification of cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

Novel complex mutation in NPM1 gene in patient with acute myeloid leukemia.Semantic proximity Read ↗

MiR-10a-5p regulates proliferation, apoptosis and cell cycle of NPM1-mutated acute myeloid leukemia cells by targeting SHANK3Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.